Fig. 3From: Clinical significance of CDH13 promoter methylation as a biomarker for bladder cancer: a meta-analysisForest plot of the association between CDH13 methylation and gender from a fixed-effects model, including 5 studies with 437 male patients and 163 female patients, OR = 1.46, 95 % CI = 0.99–2.15, P = 0.053Back to article page